Emergo Therapeutics

unknown
unknown
Stage

About

Emergo Therapeutics develops pharmaceutical treatments aimed at modulating and balancing the immune system, focusing on conditions related to cytokine dysregulation such as long COVID, influenza-like illnesses, and other respiratory viruses.

Explore Emergo Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.